![Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States](https://photos.prnewswire.com/prnfull/20150421/200124LOGO "Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States")
Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States
Novo Nordisk Pharmaceutical 00169406012 - McKesson Medical-Surgical
Victoza demonstrates efficacy in young type 2 diabetes patients - Pharmaceutical Technology
Novo Nordisk, Public Citizen duke it out over Victoza | Fierce Pharma
/cdn.vox-cdn.com/uploads/chorus_image/image/38921354/paula-deen-riding-victoza-large.0.jpg "Paula Deen's Pharma Deal Suspended by Novo Nordisk - Eater")
Paula Deen's Pharma Deal Suspended by Novo Nordisk - Eater
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OR4LHZQRIRPW7AS3O5UC7LGTWE.jpg "Novo Nordisk wins appeal over claims that diabetes drug causes cancer | Reuters")
Novo Nordisk wins appeal over claims that diabetes drug causes cancer | Reuters
Victoza Novo Nordisk A/S injektionsvæske, opløsning i fyldt pen 6 mg/ml
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
Novo Nordisk and Sandoz settle Victoza patent suit
Novo Nordisk prøver endnu engang at få bremset Victoza-kopier i USA — MedWatch
Mixed reaction to Novo Nordisk obesity trial - PMLiVE
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva - Pharmaceutical Business review
Rx Item-Victoza Pen 0.6Mg 0.1 Inj 2 By Novo Nordisk Pharm
Novo Nordisk Pharmaceutical 00169280015 - McKesson Medical-Surgical
Novo Nordisk's diabetes med Victoza chops cardiovascular risks by 13% | Fierce Pharma
Did Novo Illegally Use Diabetes Educators to Boost Drug Sales? | Insulin Nation
